Position in PCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$269,987
-$6,524,296 QoQ
Shares Held
10,642
-96.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#152
of 254 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. PCRX ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in PCRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $269,987 | 10,642 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,794,283 | 300,632 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,888,447 | 188,889 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $251,051 | 9,742 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $1,222,421 | 49,192 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $1,631,540 | 108,408 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,247,458 | 78,555 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,014,138 | 34,707 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,560,306 | 46,245 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $542,147 | 13,530 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $1,408,917 | 36,491 | Shares | Other | 2023-02-09 | |
| 2022-09-30 | $2,973,586 | 55,905 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,158,946 | 71,337 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $2,661,125 | 34,868 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $847,012 | 14,077 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $309,456 | 5,526 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,731,564 | 28,536 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $1,368,857 | 19,530 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,641,517 | 44,143 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,014,236 | 50,137 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,463,991 | 46,960 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,120,237 | 33,410 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||